L264-0132 Screening compound: N-[5-(3-chloro-4-fluorobenzenesulfonamido)-1,3-benzothiazol-2-yl]acetamide

L264-0132 Screening compound: N-[5-(3-chloro-4-fluorobenzenesulfonamido)-1,3-benzothiazol-2-yl]acetamide
L264-0132 Screening compound: N-[5-(3-chloro-4-fluorobenzenesulfonamido)-1,3-benzothiazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L264-0132
N-[5-(3-chloro-4-fluorobenzenesulfonamido)-1,3-benzothiazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L264-0132

Molecular Formula

C15H11ClFN3O3S2 (C15 H11 ClFN3 O3 S2)

Compound Name

N-[5-(3-chloro-4-fluorobenzenesulfonamido)-1,3-benzothiazol-2-yl]acetamide

IUPAC name

N-[5-(3-chloro-4-fluorobenzenesulfonamido)-13-benzothiazol-2-yl]acetamide

SMILES

CC(Nc1nc(cc(cc2)NS(c(cc3)cc(Cl)c3F)(=O)=O)c2s1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.85

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.695

Distribution Coefficient, logD

2.769

Water Solubility, LogSw

-4.07

Polar Surface Area

73.911

Acid Dissociation Constant (pKa)

6.53

Base Dissociation Constant (pKb)

3.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.70

L264-0132 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Akt-Targeted Library (14764 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L264-0132 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L264-0132?
Check Price and Availability of L264-0132, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L264-0132 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L264-0132
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L264-0132
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L264-0132 available by request